Phase 2 Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with a type of lung cancer called Non-Small Cell Lung Cancer (NSCLC) that does not have certain specific genetic mutations (such as EGFR, ALK, or ROS1)
- Your cancer is at an advanced (Stage IV) level, or your earlier-stage lung cancer has come back after treatment that was meant to cure it
- You have not had radiation therapy to the chest area before
- You have tumors in the chest (lungs and/or nearby lymph nodes) that could be treated with radiation therapy aimed at reducing symptoms
- Your cancer meets at least one "high-risk" feature, such as a large tumor (5 cm or more) not near the centre of the chest, or tumors close to important structures like the airway, esophagus, spine, heart, or major blood vessels
- You may have already received other cancer treatments (such as chemotherapy or immunotherapy), as long as you are enrolled within 6 months of starting treatment for Stage IV disease
- You are allowed to receive immunotherapy at the same time as the radiation treatment in this trial
- You have had, or are having, radiation to areas outside the chest (such as bones or the brain) for other cancer-related reasons
Who may not be able to join:
- You have previously had radiation therapy to the chest area
- You have an active autoimmune condition such as lupus or Sjögren's disease
- Your lung cancer is causing severe symptoms (such as a blocked airway, a blood clot blocking a major vein, coughing up large amounts of blood, spinal cord compression, or nerve problems in the arm) that need urgent radiation treatment for reasons other than bone pain
- Your general health and ability to carry out daily activities is significantly limited (confirm with trial site what score applies to you)
- You have cancer that has spread to the brain in a way that cannot be treated with immunotherapy alone, surgery, or targeted radiation — for example, if you need whole-brain radiation therapy
- You have a significant build-up of fluid around the lung that is clearly caused by cancer spreading across the lining of the lung (note: if you have fluid but no visible signs of cancer on the lining, you may still be eligible — confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Freedom from symptomatic progression of irradiated thoracic target(s)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.